Successful type-oriented endoscopic resection for gastric carcinoid tumors: A case report

Table 2 Clinicopathological characteristics of gastric carcinoid cases with hypergastrinemia successfully resected endoscopically or were followed-up only, published in Japan after the year (1995) of Gilligan's proposal

Authors	Age	Male/Female	Gastrin (pg/mL)	Anti-PCA/anti-IFA	Number of tumor	Size (mm)	Treatment	Tumor depth	Follow-up length (mo)
Kawaguchi[26]	33-691	10/3	74-2100	NA/NA	1 or multiple	NA	EMR	NA	NA
Hosokawa[29]	46-691	3/5	442-3800	(+) in 7/NA	multiple	1-15	follow-up only	NA	18-130
Higashino[30]	34-781	3/3	195-1800	NA/NA	1 or 2	0.732	EMR	m, sm	4-78
Ichikawa[31]	35-661	3/1	319-1122	(+) in 3/(+) in 1	1	3-8	EMR	m, sm	6-56
Shimazu[32]	65	0/1	3400	(+)/NA	9	5	EMR or hot biopsy	m	48
Yoshikane[33]	43	1/0	600	(+)/(-)	1	9	EMR	sm	9
Hori[34]	51	1/0	> 800	(+)/NA	1	7	EMR	m	144
Anjiki[35]	40	0/1	5197	(+)/(-)	3	7	EMR	sm	22
Yamamoto[36]	40's	1/0	6250	(+)/(+)	1	7	EMR	sm	12

¹Thirteen[26], eight[29], six[30] and four[31] collected cases. One case in reference [31] is omitted because of the subsequent surgery;

²Mean value; PCA: parietal cell antibody; IFA: intrinsic factor antibody; EMR: endoscopic mucosal resection; ESD: endoscopic submucosal dissection; NA: not available; m: mucosal layer; sm: submucosal layer.